Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotrophin 3 | 9 | 2018 | 13 | 1.760 |
Why?
|
| Spinal Cord Injuries | 6 | 2014 | 274 | 1.140 |
Why?
|
| Nerve Regeneration | 8 | 2013 | 72 | 1.100 |
Why?
|
| Neuronal Plasticity | 6 | 2014 | 283 | 0.910 |
Why?
|
| Axons | 8 | 2013 | 373 | 0.760 |
Why?
|
| Genetic Vectors | 18 | 2015 | 891 | 0.690 |
Why?
|
| Growth Cones | 4 | 2013 | 14 | 0.640 |
Why?
|
| Nerve Growth Factors | 5 | 2007 | 69 | 0.590 |
Why?
|
| Rats | 21 | 2018 | 3395 | 0.580 |
Why?
|
| Adenoviridae | 11 | 2015 | 573 | 0.530 |
Why?
|
| Thymidine Kinase | 8 | 2002 | 88 | 0.490 |
Why?
|
| Central Nervous System | 4 | 2006 | 272 | 0.470 |
Why?
|
| Pyramidal Tracts | 5 | 2015 | 36 | 0.470 |
Why?
|
| Wallerian Degeneration | 1 | 2013 | 8 | 0.410 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 14 | 0.410 |
Why?
|
| Cerebral Cortex | 3 | 2006 | 440 | 0.400 |
Why?
|
| Spinal Cord | 7 | 2015 | 249 | 0.400 |
Why?
|
| Gene Transfer Techniques | 4 | 2002 | 336 | 0.400 |
Why?
|
| Motor Neurons | 4 | 2007 | 122 | 0.390 |
Why?
|
| Th2 Cells | 1 | 2013 | 186 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 5 | 1998 | 1098 | 0.360 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2013 | 1127 | 0.360 |
Why?
|
| Ganciclovir | 7 | 2002 | 101 | 0.350 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2006 | 97 | 0.330 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 62 | 0.310 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 60 | 0.300 |
Why?
|
| Transduction, Genetic | 6 | 2009 | 283 | 0.300 |
Why?
|
| Neurons | 4 | 2006 | 1921 | 0.290 |
Why?
|
| Simplexvirus | 6 | 2000 | 100 | 0.280 |
Why?
|
| Protein Kinases | 1 | 2009 | 318 | 0.280 |
Why?
|
| Immunohistochemistry | 8 | 2013 | 1598 | 0.270 |
Why?
|
| Genetic Therapy | 6 | 2008 | 683 | 0.260 |
Why?
|
| Animals | 32 | 2018 | 33197 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 477 | 0.260 |
Why?
|
| Raphe Nuclei | 1 | 2005 | 16 | 0.240 |
Why?
|
| Recovery of Function | 2 | 2018 | 439 | 0.230 |
Why?
|
| Bone Marrow Cells | 2 | 2003 | 239 | 0.220 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 5 | 2008 | 23 | 0.210 |
Why?
|
| Sciatic Nerve | 4 | 2003 | 48 | 0.210 |
Why?
|
| Brain Neoplasms | 6 | 2007 | 1235 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 589 | 0.200 |
Why?
|
| Avian Sarcoma Viruses | 4 | 2000 | 30 | 0.200 |
Why?
|
| Brain | 4 | 2013 | 3041 | 0.190 |
Why?
|
| Myelin Sheath | 3 | 1993 | 119 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2003 | 517 | 0.180 |
Why?
|
| Nerve Growth Factor | 3 | 2007 | 22 | 0.180 |
Why?
|
| Mice, Neurologic Mutants | 2 | 1992 | 74 | 0.170 |
Why?
|
| Myelin Basic Protein | 2 | 1992 | 67 | 0.170 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 4446 | 0.170 |
Why?
|
| Flow Cytometry | 3 | 2013 | 755 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 377 | 0.160 |
Why?
|
| Brain Diseases | 2 | 2005 | 283 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2007 | 1868 | 0.150 |
Why?
|
| Stroke | 2 | 2018 | 1028 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2002 | 236 | 0.150 |
Why?
|
| Defective Viruses | 1 | 1997 | 17 | 0.130 |
Why?
|
| Biotin | 2 | 2007 | 39 | 0.130 |
Why?
|
| Dextrans | 2 | 2007 | 45 | 0.130 |
Why?
|
| Locomotion | 2 | 2015 | 59 | 0.130 |
Why?
|
| Epithelium, Corneal | 2 | 2008 | 171 | 0.120 |
Why?
|
| Antimetabolites | 1 | 1996 | 28 | 0.120 |
Why?
|
| p-Chloroamphetamine | 2 | 2006 | 3 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 93 | 0.120 |
Why?
|
| Mastadenovirus | 1 | 1995 | 2 | 0.120 |
Why?
|
| Viral Proteins | 1 | 1997 | 336 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 67 | 0.110 |
Why?
|
| Serotonin | 2 | 2006 | 203 | 0.110 |
Why?
|
| Chick Embryo | 2 | 2009 | 113 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 228 | 0.110 |
Why?
|
| beta-Galactosidase | 4 | 2002 | 135 | 0.110 |
Why?
|
| Rats, Nude | 1 | 2013 | 10 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2013 | 56 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 44 | 0.100 |
Why?
|
| Glioma | 2 | 1994 | 480 | 0.100 |
Why?
|
| Peripheral Nerve Injuries | 1 | 1993 | 36 | 0.100 |
Why?
|
| Rats, Inbred F344 | 4 | 2002 | 98 | 0.100 |
Why?
|
| Schwann Cells | 1 | 1993 | 56 | 0.100 |
Why?
|
| Cell Survival | 4 | 2008 | 840 | 0.100 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 361 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2007 | 1199 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 524 | 0.090 |
Why?
|
| Female | 13 | 2018 | 68638 | 0.090 |
Why?
|
| Limbus Corneae | 2 | 2007 | 32 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1232 | 0.080 |
Why?
|
| Nerve Net | 1 | 2013 | 244 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2009 | 1015 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2007 | 2541 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 1992 | 2311 | 0.080 |
Why?
|
| Antiviral Agents | 4 | 2002 | 776 | 0.070 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2007 | 16 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2003 | 684 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 23 | 0.070 |
Why?
|
| Time Factors | 4 | 2018 | 6163 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 972 | 0.070 |
Why?
|
| Facial Muscles | 2 | 1998 | 25 | 0.070 |
Why?
|
| Facial Nerve | 2 | 1998 | 25 | 0.070 |
Why?
|
| Stem Cells | 3 | 2008 | 682 | 0.070 |
Why?
|
| Nerve Crush | 3 | 1998 | 6 | 0.070 |
Why?
|
| Receptor, trkA | 1 | 2007 | 15 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 415 | 0.070 |
Why?
|
| Injections, Intramuscular | 2 | 2018 | 182 | 0.070 |
Why?
|
| Microglia | 1 | 2007 | 128 | 0.060 |
Why?
|
| Signal Transduction | 1 | 1998 | 4485 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 291 | 0.060 |
Why?
|
| Serotonin Agents | 1 | 2006 | 15 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 951 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 415 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 58 | 0.060 |
Why?
|
| Gene Expression | 3 | 2007 | 1485 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2005 | 260 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 2312 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 948 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 654 | 0.050 |
Why?
|
| Medulloblastoma | 1 | 2007 | 379 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 973 | 0.050 |
Why?
|
| Mice | 8 | 2013 | 17686 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 155 | 0.050 |
Why?
|
| Cornea | 1 | 2007 | 551 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 1142 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 827 | 0.050 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2003 | 162 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 160 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 326 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 231 | 0.050 |
Why?
|
| Neurites | 1 | 2001 | 42 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2001 | 62 | 0.040 |
Why?
|
| Dependovirus | 1 | 2002 | 144 | 0.040 |
Why?
|
| Software | 1 | 2006 | 711 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 719 | 0.040 |
Why?
|
| Cell Communication | 1 | 2001 | 190 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2007 | 871 | 0.040 |
Why?
|
| Survival Rate | 2 | 1995 | 2111 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2007 | 414 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 573 | 0.040 |
Why?
|
| Memory | 1 | 2002 | 345 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2007 | 363 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 6 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2891 | 0.040 |
Why?
|
| Algorithms | 1 | 2006 | 1635 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 825 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 446 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 985 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1711 | 0.040 |
Why?
|
| Radiography | 2 | 2000 | 755 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 419 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 73 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1997 | 41 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 82 | 0.030 |
Why?
|
| Pons | 1 | 1997 | 33 | 0.030 |
Why?
|
| Sigmodontinae | 1 | 1997 | 44 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 86 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2002 | 693 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 4513 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 69 | 0.030 |
Why?
|
| Ciliary Neurotrophic Factor | 2 | 1993 | 10 | 0.030 |
Why?
|
| Papio | 1 | 1996 | 57 | 0.030 |
Why?
|
| Virus Shedding | 1 | 1996 | 75 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2003 | 12572 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 155 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 41 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1996 | 225 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 40 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 395 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1597 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 1206 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1998 | 1015 | 0.030 |
Why?
|
| Forelimb | 1 | 2014 | 12 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 1994 | 15 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 1484 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 448 | 0.030 |
Why?
|
| Denervation | 1 | 2014 | 26 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 361 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3715 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 1168 | 0.030 |
Why?
|
| Brain Stem | 1 | 2014 | 109 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 348 | 0.030 |
Why?
|
| Receptor, EphA4 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Ephrin-B3 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1395 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 131 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1993 | 81 | 0.020 |
Why?
|
| Pia Mater | 1 | 1992 | 9 | 0.020 |
Why?
|
| Median Eminence | 1 | 1992 | 4 | 0.020 |
Why?
|
| Choroid Plexus | 1 | 1992 | 24 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 1992 | 70 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2015 | 362 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2898 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 1992 | 80 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1992 | 98 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 130 | 0.020 |
Why?
|
| Humans | 9 | 2015 | 127335 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 291 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 309 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1992 | 108 | 0.020 |
Why?
|
| Reference Values | 1 | 1992 | 684 | 0.020 |
Why?
|
| Macrophages | 1 | 1994 | 644 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 1133 | 0.020 |
Why?
|
| Astrocytes | 1 | 1992 | 261 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1990 | 75 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 460 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2543 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2803 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2008 | 42 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3587 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2007 | 5 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 8 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2007 | 104 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 203 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 189 | 0.020 |
Why?
|
| Male | 5 | 2014 | 62795 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 672 | 0.010 |
Why?
|
| Seizures | 1 | 1990 | 847 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 2598 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 656 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 55 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 36 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2002 | 16 | 0.010 |
Why?
|
| Methylnitrosourea | 1 | 2002 | 15 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 43 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2002 | 51 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 237 | 0.010 |
Why?
|
| Carcinogens | 1 | 2002 | 128 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2001 | 80 | 0.010 |
Why?
|
| Laminin | 1 | 2001 | 67 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 1325 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2001 | 230 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 125 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 271 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 308 | 0.010 |
Why?
|
| Gliosarcoma | 1 | 2000 | 7 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 292 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2398 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2001 | 302 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1569 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 406 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2000 | 96 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 606 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 3235 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 900 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 979 | 0.010 |
Why?
|
| Aged | 2 | 2008 | 20433 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 1235 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2000 | 335 | 0.010 |
Why?
|
| Middle Aged | 2 | 2008 | 27818 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 3261 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 9698 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 30544 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1994 | 708 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 23 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 199 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 235 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 422 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1992 | 680 | 0.000 |
Why?
|